Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

4/6/2014 (1 year ago)

Catholic Online (www.catholic.org)

Drug cut in half the risk that cancer would worsen

An important treatment option in the fight against breast cancer may be waiting in the wings. Researchers say a new type of drug could help prevent advanced breast cancer from worsening. The potential is great for breast cancer patients, and makes for a potential blockbuster product for Pfizer.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

4/6/2014 (1 year ago)

Published in Health

Keywords: Pfizer, breast cancer, palbociclib


LOS ANGELES, CA (Catholic Online) - Said drug cut in half the risk that cancer would worsen, or progress, researchers said. The median time before the disease progressed or the women died was 20.2 months for those who received the drug, compared with 10.2 months for the control group.

"The magnitude of benefit we are seeing is not something commonly seen in cancer medicine studies," Dr. Richard S. Finn, a principal investigator in the study, says. Finn, an oncologist at the University of California, Los Angeles, called the results "quite groundbreaking."

No child need ever go to bed hungry -- Learn how you can help!


Known as palbociclib, the drug also appeared to prolong survival but not by a statistically significant amount. Those who received the drug lived a median of 37.5 months in contrast with 33.3 months for those in the control group.

The results from the Phase 2, or mid-stage, study were presented here at the annual meeting of the American Association for Cancer Research. Palbociclib is considered a jewel in Pfizer's product pipeline, with analysts predicting annual sales of billions of dollars. Amgen is entitled to an eight percent royalty on sales of the drug.

Some investors may have been letdown due to the drug, partly because they were not quite as good as interim results presented about halfway through the trial. At that point, the difference in median progression-free survival was 26.1 months for palbociclib versus 7.5 months for the control group.

Finn stresses that a statistically significant survival benefit should not have been expected at this point because only 61 of the 165 patients in the trial had died. Patients can use other drugs after leaving the trial, which can dilute any effect of palbociclib.

Palbociclib slows the proliferation of cancer cells by inhibiting the activity of two related enzymes involved in cell division; cyclin-dependent kinases 4 and 6.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor. While breast cancer is the initial focus, the drugs are being tested for other cancers.

Breast cancer specialists not involved in the study were encouraged -- but expressed caution. "These results are strikingly positive and with a large potential impact to patients," Dr. José Baselga said in a speech at the conference discussing the results.

Baselga, the physician in chief at the Memorial Sloan-Kettering Cancer Center, also said the results might have been biased because the study investigators, who determined whether tumors had progressed, knew which patients were getting palbociclib.

Dr. Eric P. Winer, chief of women's cancers at the Dana-Farber Cancer Institute in Boston, says larger studies were still needed.

"This is a small Phase 2 trial - not tiny, but not the kind of study that would typically lead to a change in practice," he said.

---


Pope Francis: end world hunger through 'Prayer and Action'


Copywriter 2015 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for July 2015
Universal:
That political responsibility may be lived at all levels as a high form of charity.
Evangelization: That, amid social inequalities, Latin American Christians may bear witness to love for the poor and contribute to a more fraternal society.



Comments


More Health

12,000 children may be exposed to HIV and Hepatitis from unsterile surgical equipment at hospital Watch

Image of The Seattle Children's Hospital is under controversy once again.

By Linky C. (NEWS CONSORTIUM)

Seattle's Bellevue clinic Children's Hospital contacts the parents of 12,000 children who might have been exposed to HIV and hepatitis due to un-sterile surgical equipment. MUNTINLUPA CITY, PHILIPPINES (Catholic Online) - Parents of roughly 12,000 children who were ... continue reading


High vaccination rates help protect communities Watch

Image of Pockets of unvaccinated people pose health risks to the immune-compromised population.

By Kenya Sinclair (NEWS CONSORTIUM)

Following the Disneyland Measles outbreak, more and more U.S. parents are vaccinating their children. Despite the increased number of "vaccinators," "anti-vaccers" pose a public health risk. LOS ANGELES, CA (Catholic Online) - The U.S. Centers for Disease Control and ... continue reading


The Universal Flu Vaccine: Researchers are closer to a solution that attacks a different part of the virus Watch

Image of Human immune response to influenza is directed against a protein on the virus called hemagglutinin, and a portion of the protein called the hemagglutinin head, where the majority of the mutations occur.

By Catholic Online (NEWS CONSORTIUM)

It's a universal misery that comes whenever the weather cools or it starts to rain. Influenza begins to settle in to a large part of the population, leading to school and job absences. Researchers now say hat attacking a largely hidden part of the influenza ... continue reading


Grandmother miraculously beats eight different cancers in a row Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

Many people lose hope while battling cancer and experience even more trauma when they fight the same disease again and again. Despite the constant evolution of technology, there are still risks of developing different forms of cancer at any time. However, one ... continue reading


Hepatitis C finally given approval in United Kingdom after 'inexcusable wait' Watch

Image of Sufferer Pamela Anderson claims she got Hepatitis C from her ex-husband Tommy Lee after they shared tattoo needles.

By Catholic Online (NEWS CONSORTIUM)

It comes as wonderful news for untold thousands of Hepatitis C sufferers, albeit one that came after an "Inexcusable wait." The once-a-day drug sofosbuvir has a 90 percent success rate by patients - and will be available free of charge for patients in the ... continue reading


First human brain grown in laboratory dubbed success, despite scientific doubt Watch

Image of

By Talia Ramos (NEWS CONSORTIUM)

For the first time in the history of science, an almost full-grown human brain was successfully grown outside the body and in a laboratory by a team of researchers. According to The Guardian, the brain is a size comparable to that of a 5-week-old fetus. The brain will ... continue reading


Modern Paleo diet may not be so Paleolithic Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

Carbohydrates, largely overlooked in the modern Paleo diet, were actually a part of the food group consumed by our hunting-and-gathering forefathers, according to a new study published earlier this month. Although the diet works effectively on some trying to lose ... continue reading


Is coffee really good for you? New research finds coffee may reduce risk of some cancers Watch

Image of

By Hannah Marfil (NEWS CONSORTIUM)

Caffeinated coffee drinkers are at a lower risk of having bowel cancer, as well as dying from the disease and other types, according to recent data. Those who drink four to five mugs of coffee a day were found to cut, by almost a half, the odds of bowel cancer ... continue reading


'Brainy' mice research may lead to effective treatment for Alzheimer's Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

Genetically altered mice tend to be more intelligent and exhibit less anxiety, according to new research. The discovery is speculated to be a part of a more comprehensive study regarding treatment to diseases like Alzheimer's post-traumatic stress disorder (PTSD) and ... continue reading


Study finds intelligence related to a longer lifespan Watch

Image of

By Talia Ramos (NEWS CONSORTIUM)

A longer lifespan is related to intelligence contributed by the genetic makeup, according to new research. Analyzing three twin studies, a research team found that the link between intelligence and a person's life expectancy is about 95 percent because of genetics, ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, Jeremiah 1:17-19
17 'As for you, prepare yourself for action. Stand up ... Read More

Psalm, Psalms 71:1-2, 3-4, 5-6, 15, 17
1 In you, Yahweh, I take refuge, I shall never be put ... Read More

Saint of the Day

Saint of the Day for August 29th, 2015 Image

St. Sabina
August 29: St. Sabina's feast day is August 29th. We know St. Sabina only ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter